Deciphering pancreatic neuroendocrine tumors: Unveiling through circulating small extracellular vesicles

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Pancreatic neuroendocrine tumors (PanNET) have a lower survival rate due to late detection.
• Lack of specific early-stage diagnostic markers hinders timely intervention for PanNET.
• Small extracellular vesicles (sEVs) are increasingly recognized for their role in cancer progression.

Purpose of the Study:

• To investigate the potential of small extracellular vesicles (sEVs) as early-stage biomarkers for PanNET.
• To explore the correlation between sEV concentration and PanNET presence and grade.
• To identify specific markers within sEVs and PanNET tissue relevant to cancer and autophagy.

Main Methods:

• Quantification of sEV concentrations in plasma samples from PanNET patients and controls.
• Analysis of sEV marker expression using specific antibodies (CD63, TSG101, CD9, Flotillin-1, GAD65).
• Assessment of cancer marker BIRC2/cIAP1 and autophagy marker Beclin-1 expression in plasma-derived sEVs and PanNET tissue.

Main Results:

• Significantly higher sEV concentrations were observed in PanNET patients compared to controls (p < 0.0001), with 100% sensitivity.
• Distinct differences in sEV concentrations were found between controls and Grade 1 PanNET (p = 0.005).
• Expression of sEV markers, cancer marker BIRC2/cIAP1, and autophagy marker Beclin-1 were confirmed.

Conclusions:

• This study is the first to report increased sEV secretion in the blood plasma of PanNET patients.
• Plasma-derived sEVs show promise as a novel, sensitive biomarker for early-stage PanNET detection.
• The findings suggest a potential role for sEVs in PanNET growth and metastasis.